ArticleClinical Medicine Insights. Cardiology2025

Evaluating the Safety and Efficacy of SGLT-2 Inhibitors on Reducing Cardiovascular and Renal Mortality, Morbidity and Inflammatory Outcomes in Various Patient Populations: A Systematic Review and Meta-Analysis of 92 920 Patients.

Syed Hamza Haider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.